Weekly Rundown: Key Catalysts for Small-Cap Stocks (December 8-12)

From recent disclosures to corporate shifts, we’ve highlighted the top small-cap catalysts to watch. Here’s your weekly preview (December 8-12).

--

Small Cap companies with Material events this week:

• GOSS > the Company will participate in the Oppenheimer Movers in Rare Disease Summit December 11th, at 9:00 AM ET.

• LXRX > clinical data on adipose tissue distribution in non-diabetic patients treated with sotagliflozin will be presented at the 22nd Global Cardiovascular Clinical Trialists Forum (CVCT 2025), December 8-10 in Washington, D.C.

• SLMT > as a strategic partner of Abu Dhabi Finance Week (December 8-11), Solmate's CEO will deliver a joint keynote on December 10 outlining the company’s vision for Abu Dhabi’s role in institutional digital asset infrastructure.

• RZLV > will participate in a virtual fireside chat moderated by Maxim on December 8 at 10 a.m. ET.

• FUFU > announced sponsorship of Bitcoin MENA 2025, taking place December 8-9 in Abu Dhabi.

• TCRX > to host a virtual KOL event featuring Ran Reshef, M.D., on December 8 at 8:00 a.m. ET.

• BIAF > will present a poster at the American Cancer Society National Lung Cancer Roundtable on December 8, showcasing CyPath® Lung data.

• LGVN > executives will speak on multiple panels at CVCT Forum, December 8-10 in Washington, D.C.

• ECOR > publication on vagal nerve stimulation will be presented at AHFE2025 on December 8.

• ALEC > to participate in Bank of America CNS Therapeutics Conference on December 8 at 2:25 p.m. ET.

• RXRX > will present new data from the TUPELO Phase 1b/2 trial during a webinar on December 8.

• MGX > will present new preclinical APOC3 data at the Nature Conference in Boston, December 8-10.

• AMBO > to host an Investor Event & Tech Showcase on December 8 from 2–4:30 p.m. PST in San Diego and virtually.

• OSTX > completed submissions for pre-MAA meeting with MHRA (Dec 8) and FDA Type C meeting (Dec 11).

• NRSN > investor update meeting on December 8 at 8:30 a.m. ET covering ALS, Alzheimer's, and regulatory plans.

• MMLP > will participate in Wells Fargo Energy and Power Symposium on December 9 in NYC.

• FFAI > Steven Park to present at the Q4 Investor Summit Virtual on December 9.

• INTS > announces two presentations at the 2025 SABCS in San Antonio, December 9-12.

• FLUX > to present at iAccess Alpha Virtual Best Ideas Conference on December 9 at 4:00 p.m. ET.

• BOSC > will present at both the Q4 Investor Summit Virtual and iAccess Alpha Conference, December 9-10.

• REI > to participate in a fireside chat with Water Tower Research on December 9 at 10:00 a.m. CT.

• UPXI > will attend Solana Breakpoint 2025, December 11-13.

• BLZE > will present at Gartner IOCS Conference, December 9-11 in Las Vegas.

• GELS > CEO to present at Q4 Investor Summit Virtual on December 9.

• IMMP > new AIPAC-003 trial data to be presented at SABCS, December 9-12.

• GAME > CEO to present at iAccess Alpha Conference on December 9 and meet with investors on December 10.

• TDAY > CEO and CFO will attend UBS Global Media & Communications Conference on December 9.

• DGXX > to participate in iAccess Alpha Virtual Conference, December 9-10.

• RNXT > to participate in iAccess Alpha Virtual Conference, December 9-10.

• SCNX > will participate in iAccess Alpha Conference, December 9-10.

• DYAI > will present at iAccess Alpha Virtual Best Ideas Conference, December 9-10.

• PSTV > abstract accepted for poster spotlight at SABCS, December 9-12.

• CMRC > to present at Raymond James Tech Conference on December 9 and Barclays Tech Conference on December 11.

• BIVI > CEO to host webinar on December 9 at 4:15 p.m. ET to discuss Alzheimer’s and liver cirrhosis programs.

• ATOS > four abstracts featuring (Z)-endoxifen accepted for SABCS, December 9-12.

• HOVR > will sponsor and participate in OAC's Aerospace Unplugged event on December 9.

• SPWR > to attend Wells Fargo Energy & Power Symposium in NYC, December 9-10.

• TNMG > to host INSIDE Future Day on next-gen AI agents in Taipei, December 9.

• LRE > management to present at Sidoti Year-End Virtual Conference on December 11 at 10:00 a.m. ET.

• IRIX > will present at Sidoti Conference on December 11 at 10:45 a.m. ET.

• TOMZ > to present at Sidoti Conference and hold 1-on-1s on December 10-11.

• GAIA > to present at Sidoti Virtual Investor Conference, December 10-11.

• AMPG > will host Investor Demo Day at its NY HQ on December 10 from 4:30–6:15 p.m.

• PPBT > to present CAPTN-3 preclinical data at ESMO-IO Congress, December 10-12 in London.

• XBP > will participate in Sidoti Year-End Virtual Investor Conference, December 10-11.

• SRFM > to present at H.C. Wainwright AeroNext Virtual Conference on December 10 at 12:00 p.m. ET.

• OSRH > to present at Emerging Growth Conference on December 10 at 9:05 a.m. ET.

• DRTS > will present two abstracts at ASCO GI Symposium, January 8-10, 2026.

• FEAM > to participate in RedChip's Virtual Conference on December 10.

• FMST > to participate in RedChip's Virtual Conference on December 10.

• TII > to participate in RedChip's Virtual Conference on December 10.

• PYPD > to participate in KOL event hosted by ROTH on December 10 at 11:30 a.m. ET.

• UIS > will attend Sidoti Virtual Conference on December 10-11.

• ZSPC > will exhibit AR/VR tech at ACTE CareerTech VISION, December 10-11.

• PLBY > to attend Roth’s Deer Valley Event, December 10-13.

• KLXE > to present at Emerging Growth Conference virtually on December 10.

• COCH > to host fireside chat on December 11 at 4:30 p.m. ET.

• ENLV > to hold virtual fireside chat on December 11 at 11:00 a.m. ET.

• VNCE > to participate in KeyBanc Consumer Conference on December 11 at 2:25 p.m. ET.

• PFSA > to present clinical update at PVI 2025 in Paris, December 11-13.

• QNCX > to present at Oppenheimer Rare Disease Summit on December 11.

• CMMB > to present at Oppenheimer Rare Disease Summit on December 11.

• INO > to join Rare Disease Summit panel on December 11 and conduct 1-on-1s.

• MIGI > to present at Emerging Growth Conference on December 11 at 1:10 p.m. ET.

• ANIX > breast cancer vaccine data to be presented at SABCS on December 11.

• ABSI > to host KOL seminar on December 11 discussing ABS-201 program.

• MIST > CARDAMYST NDA under review with FDA; PDUFA action date is December 13, 2025.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.